Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 09 - 13    tags : Phase 3    save search

Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome
Published: 2021-09-13 (Crawled : 12:00) - zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.9% C: -0.45%

phase 3 trial syndros zygel
Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Durable Overall Survival at Three Years Compared to Chemotherapy in First-Line Unresectable Malignant Pleural Mesothelioma in Phase 3 CheckMate -743 Trial
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 0.06% C: -0.99%

therapy phase 3 trial nivolumab
Syros to Present New Data from Phase 1 Clinical Trial of SY-5609 in Oral Presentation at ESMO Congress 2021
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
SYRS | $4.76 -6.85% -7.35% 120K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 6.9% C: 3.16%

presentation phase 1 trial phase 2 phase 3
TCR2 Therapeutics to Announce Extended Results from Ongoing Phase 1/2 Trial of Gavo-cel in Mesothelin-Expressing Solid Tumors
Published: 2021-09-13 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M twitter stocktwits trandingview |
Health Technology
| | O: 1.71% H: 3.42% C: -0.27%

solid tumors ongoing phase 1 results trial phase 2 phase 3 cel
VistaGen Therapeutics Further Advances PALISADE Phase 3 Program for PH94B in Social Anxiety Disorder with Initiation of PALISADE-2
Published: 2021-09-13 (Crawled : 10:00) - ir.vistagen.com
VTGN | $4.69 0.43% 0.43% 200K twitter stocktwits trandingview |
Health Technology
| | O: 1.66% H: 4.89% C: -1.63%

phase 3 social anxiety disorder ph94
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.